Sort

Search

14/01/2025 Posterior Cortical Atrophy Due to Alzheimer Disease in a Person With Down Syndrome
Rodríguez-Baz, I, Benejam, B, Morcillo-Nieto, AO, Vaqué-Alcázar, L, Arriola-Infante, JE, Camacho, V, Aranha, MR, Carmona-Iragui, M, Videla, L, Barroeta, I, Fernández, S, Zsadanyi, SE, Giménez, S, Arranz, J, Blesa, LM, Alcolea, D, Lleó, A, Bejanin, A, Fortea, J. Posterior Cortical Atrophy Due to Alzheimer Disease in a Person With Down Syndrome. NEUROLOGY. 2025; 104(1)DOI:10.1212/WNL.0000000000210179. PMID:39689339. IF:8.500(Q1/1D).
11/01/2025 Do Unresectable Giant Cell Tumors of Bone Treated With Denosumab Progress After Discontinuation of Treatment?
de la Calva, C, Angulo, M, González-Rojo, P, Peiró, A, Machado, P, Cebrián, JL, García-Maroto, R, Valcárcel, A, Puertas, P, Valero-Cifuentes, G, Pablos, O, Maireles, M, Fontalva, ML, Chaves, I, Orce, A, Coll-Mesa, L, Pérez, I, González, F, Sanz, MD, Gracia, I. Do Unresectable Giant Cell Tumors of Bone Treated With Denosumab Progress After Discontinuation of Treatment?. Cancer Reports. 2025; 8(1)DOI:10.1002/cnr2.70117. PMID:39797695. IF:(Q/D).
11/01/2025 Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group
Oñate, G, Garrido, A, Arnan, M, Pomares, H, Alonso, E, Tormo, M, Diaz-Beya, M, Vives, S, Zamora, L, Sampol, A, Coll, R, Salamero, O, Cervera, M, Garcia, A, Vall-Llovera, F, Garcia-Avila, S, Bargay, J, Ortin, X, Iranzo, E, Guijarro, F, Pratcorona, M, Nomdedeu, JF, Esteve, J, Sierra, J. Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group. Blood Cancer Journal. 2025; 15(1)DOI:10.1038/s41408-024-01205-5. PMID:39799145. IF:11.600(Q1/1D).
10/01/2025 Variations and Opportunities in Postnatal Management of Hemolytic Disease of the Fetus and Newborn
de Winter, DP, Verweij, EJT, Debeer, A, Devlieger, R, Lewi, L, Verbeeck, S, Maurice, P, Jouannic, JM, Guillemin, MG, Mailloux, A, dos Santos, MCP, Pacheco, CADS, Moreira, MEL, Vaena, MMD, Bohlin, K, Tiblad, E, Thorup, E, Petersen, OB, Sanchez-Holgado, M, Llorente, AV, Poljak, B, Khalil, A, Le Duc, K, Ghesquiere, L, Krivec, JL, Soltirovska-Salamon, A, Dame, C, Blank, JD, Hohnecker, A, Saxonhouse, M, Connors, NK, Geipel, A, Rath, J, Prasad, S, van Wyk, L, Geerts, L, Schuler, R, Thon, N, Leibovitch, L, Cohen, S, Canul-Euan, AA, Kelly, E, Raghuram, K, Cavigioli, F, Colombo, SFG, Elanjikal, Z, Brayley, J, Pfurtscheller, D, Pichler, G, Grisi, AGA, Navarro, EJJC, Pereira-Nunes, J, Soares, H, Zhou, M, Borau, MJG, Calderon, EM, Galletti, MF, Mariani, GL, Mackin, D, Malone, F, Lampland, A, Tse, WT, Castleman, J, van der Bom, JG, de Haas, M, Lopriore, E, Fetus Newborn DIONYSUS Investigators. Variations and Opportunities in Postnatal Management of Hemolytic Disease of the Fetus and Newborn. JAMA Network Open. 2025; 8(1)DOI:10.1001/jamanetworkopen.2024.54330. PMID:39792381. IF:9.700(Q1/1D).